Evidence map›Paper›PMID 35734332›Full record

ArticleThe Pan African medical journal2022

COVID-19 pandemic impact on neurologic emergencies: a single-center retrospective cohort study.

Maria Gavriilaki, Eleni Karlafti, Maria Moschou, Konstantinos Notas, Marianthi Arnaoutoglou, Georgia Kaiafa, Christos Savopoulos, Vasilios Kimiskidis

Abstract read
In one paragraph

Article in The Pan African medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maria GavriilakiFirst Department of Neurology, American Hellenic Educational Progressive Association (AHEPA), University Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Eleni KarlaftiFirst Department of Propaedeutic and Internal Medicine, American Hellenic Educational Progressive Association (AHEPA), University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Maria MoschouFirst Department of Neurology, American Hellenic Educational Progressive Association (AHEPA), University Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Konstantinos NotasLaboratory of Clinical Neurophysiology, American Hellenic Educational Progressive Association (AHEPA) University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Marianthi ArnaoutoglouLaboratory of Clinical Neurophysiology, American Hellenic Educational Progressive Association (AHEPA) University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Georgia KaiafaFirst Department of Propaedeutic and Internal Medicine, American Hellenic Educational Progressive Association (AHEPA), University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Christos SavopoulosFirst Department of Propaedeutic and Internal Medicine, American Hellenic Educational Progressive Association (AHEPA), University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Vasilios KimiskidisFirst Department of Neurology, American Hellenic Educational Progressive Association (AHEPA), University Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: COVID-19 pandemic caused a major disruption to healthcare system. A year after COVID-19 outbreak, the question remains to what extent the lockdowns changed the volume of non-infected patients who were admitted to the Neurologic Department (ND). To determine the impact of the pandemic´s first year on a tertiary ND. Methods: non-infected patients admitted to ND between March 2020 and February 2021 were examined. A control group was generated for the same time interval starting from March 2019. Primary outcomes were the number of patients presenting with neurologic complaint who were admitted to the hospital and the diagnosis type. Secondary outcomes were hospitalization length and patients´ outcome. Results: overall, 816 patients (49.4% females) were admitted during the predetermined periods. Median age was 55 years. Median length of hospitalization was six days. We observed a 47.2% reduction in our department´s admissions during pandemic (n=282). None of the examined variables (type of neurologic diagnosis, age, gender, hospitalization length and outcome) changed significantly during pandemic. However, the number of patients admitted during the pandemic with a diagnosis categorized as "other" was statistically significant lower compared to the year before COVID-19 (p=0.007). Hospitalization length was associated only with patients´ age. Conclusion: our study examined for the first-time the consequences of the first year of COVID-19 pandemic on ND admissions. COVID-19 outbreak resulted in decreased admissions. Delays in seeking medical consultation for urgent or undiagnosed neurologic conditions require rigorous long-term monitoring to fully understand the impact of COVID-19 pandemic on patients with neurologic diseases.

Indexed as

COVID-19Nervous System DiseasesCommunicable Disease ControlEmergenciesEmergency Service, HospitalFemaleHospitalizationHumansMaleMiddle AgedPandemicsRetrospective StudiesSARS-CoV-2COVID-19Emergency servicehospitalnervous system diseasesSARS-CoV-2

Identifiers

PMID35734332
PMCPMC9187993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.